General Information of Drug (ID: DME617W)

Drug Name
Neucardin Drug Info
Synonyms Human neuregulin-1 recombinant peptide fragment (injectable, heart failure/cardiomyopathy), Zensun; RhNRG-1 (injectable, heartfailure/cardiomyopathy), Zensun
Indication
Disease Entry ICD 11 Status REF
Heart failure BD10-BD13 Phase 3 [1]
Chronic heart failure BD1Z Phase 2 [2]
Cross-matching ID
TTD Drug ID
DME617W

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Pro-neuregulin-1 (Pro-NRG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GGF DMVWYOU Congestive heart failure BD10 Phase 1b [4]
GGF-2 DMDMPKC Heart failure BD10-BD13 Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Pro-neuregulin-1 (Pro-NRG1) TTEH395 NRG1_HUMAN Modulator [3]

References

1 ClinicalTrials.gov (NCT01214096) Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
4 Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J Cell Biol. 2001 Mar 19;152(6):1289-99.